We respect your privacy. Please consent to all cookies when you visit our website. Refer to our "Privacy Policy" for more information on how we handle personal data.

EN
  • 02.png
Medical Device Reg. No. 20262400142 (Guangdong)

Heparin-Binding Protein (HBP) Assay Kit (Chemiluminescence Immunoassay)

Infection is a major threat to global public health. According to WHO's Global Health Estimates 2023, infectious diseases cause approximately 13.7 million deaths annually, accounting for nearly a quarter of total global deaths. Sepsis, a systemic inflammatory response syndrome triggered by infection, carries a mortality rate of 20%–40%, while severe sepsis and septic shock can exceed 50%. Shanghai Berger Inflammation Factor Series markers enable early identification, precise classification, assessment of severity, guidance on antibiotic use, and efficacy monitoring — improving diagnostic and treatment efficiency and safety.

  • Rapid Results

    Results available within 20 minutes, meeting the needs of rapid clinical testing.

  • Flexible Configuration

    Suitable for differentiating bacterial and viral infections, severe disease risk stratification, and various other applications

  • Comprehensive Applications

    Outpatient and emergency departments, ICUs, postoperative monitoring, therapeutic efficacy evaluation, and more

  • High Cost-Effectiveness

    Reagent kits include calibrators and quality controls, providing greater cost-effectiveness

image.png